I am a graduate of the Faculty of Pharmacy at the Medical University of Gdańsk (GUMed), Head of the Department of Pharmaceutical Pathophysiology, and Deputy Director of the First Doctoral School at GUMed. I completed two postdoctoral research fellowships at Trinity College Dublin, where I conducted studies on the pharmacological activity of new aspirin analogues, as well as on nanopharmacology and nanotoxicology in vitro. My scientific interests focus on experimental nanomedicine, platelet pharmacology, studies on platelet–cancer cell interactions and the role of platelets in cancer metastasis, as well as research aimed at developing targeted therapies for pancreatic cancer. I am the principal investigator of several research projects funded by the National Science Centre (NCN), including OPUS (evaluation of the potential anticancer activity of new analogues of the opioid growth factor in pancreatic cancer therapy), HARMONIA (assessment of the antithrombotic and antiplatelet effects of functionalized silver nanoparticles), and OPUS LAP (investigation of the potential use of NK cells and graphene oxide nanoparticles in the immunotherapy of pancreatic ductal adenocarcinoma). I also serve as the project leader (on behalf of our university within a scientific consortium) in the European Horizon Programme grant PRECODE, focused on developing a three-dimensional pancreatic cancer model based on patient-derived organoids, as well as in the STER NAWA project supporting the internationalization of the doctoral school. In addition, I am a scientific supervisor in three PRELUDIUM grants and five internal university grants under the Young Creator of Science program. For the past four years, I have been included among the prestigious top 2% of the world’s most influential scientists. I collaborate with Trinity College Dublin, University Hospital Erlangen, the University of Saskatchewan, the University of Janina, the University of Milan, the Luxembourg Institute of Health, Gdańsk University of Technology, the University of Gdańsk, and the University of Warsaw. I have supervised seven completed PhD dissertations and am currently supervising four ongoing ones. One of my doctoral students defended— as the first at our university— a PhD thesis in experimental nanomedicine while still a sixth-year medical student, conducting research as part of a student scientific society project. I also serve as a reviewer of doctoral and habilitation theses, as well as in proceedings for the conferment of the title of professor.